Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
Links relacionados
- Similares em SciELO
- uBio
Compartilhar
Acta bioquímica clínica latinoamericana
versão impressa ISSN 0325-2957versão On-line ISSN 1851-6114
Resumo
MUJICA TORRES, Abril et al. Hemoglobina glucosilada en el diagnóstico de diabetes gestacional en mujeres mexicanas durante el tercer trimestre. Acta bioquím. clín. latinoam. [online]. 2021, vol.55, n.4, pp.439-443. ISSN 0325-2957.
The objective of this study was to analise glycosylated hemoglobin values in the third trimester of pregnancy as an alternative predictor of gestational diabetes in North East Mexican cohort patients. This is a retrospective case-control study based on 121 records of pregnant patients, divided into two groups, patients with gestational diabetes (cases) and pregnant women with normal glycemic values (control). The risk factors associated with gestational diabetes were analised and a cut-off point for glycosylated hemogestaglobin was obtained. It was found that maternal obesity, age and a history of the condition were significantly associated with gestational diabetes. Values of glycosylated hemoglobin ≥5% increased the risk of suffering from gestational diabetes 4 times, and coupled with a risk factor, the risk increased 7 times. It is concluded that glycosylated hemoglobin values in the third trimester of pregnancy could be used as a diagnostic test for gestational diabetes in patients from the North East of Mexico. Although the differences found were statistically significant, our results must be interpreted with caution and require confirmation by studies with a larger sample.
Palavras-chave : Gestational diabetes mellitus; Glycosylated hemoglobin; Third trimester; Oral glucose tolerance curve; Metabolic disorder; Diagnosis.